Spots Global Cancer Trial Database for cytoreductive prostatectomy
Every month we try and update this database with for cytoreductive prostatectomy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer | NCT06306612 | Prostate Cancer | Systemic Chemoh... Systemic Hormon... Cytoreductive P... Postoperative A... | 18 Years - 85 Years | RenJi Hospital | |
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients | NCT06350825 | Metastatic Pros... Therapy, Direct... | Cytoreductive p... ADT+second-gene... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients | NCT06350825 | Metastatic Pros... Therapy, Direct... | Cytoreductive p... ADT+second-gene... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients | NCT06350825 | Metastatic Pros... Therapy, Direct... | Cytoreductive p... ADT+second-gene... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University |